For liraglutide, 21.8% of patients doubled their weight loss, 15.9% lost some additional weight, and 14.2% maintained their loss, with 51.9% in total maintaining or losing more weight
While there have been improvements in survival over the last decade, progress has been incremental and the mortality rate remains the highest amongst solid malignancies (5-year survival rate of 13%) 2
20 The study design with two reference groups (diabetes and overweight/obese) served to mitigate the influence of potential confounding factors
137 For time efficiency, brief questionnaires that assess multiple lifestyle behaviors include the Lifestyle Medicine Assessment 138 and Lifestyle Medicine Health Behavior Scale
In plain terms, it draws a smooth curve between the weight-loss data points reported at each stage of the trial
Thinking about Ozempic or GLP-1